1. Home
  2. BKSY vs IMMP Comparison

BKSY vs IMMP Comparison

Compare BKSY & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$23.24

Market Cap

839.0M

Sector

Technology

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$0.26

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKSY
IMMP
Founded
2013
1987
Country
United States
Australia
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
839.0M
42.4M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
BKSY
IMMP
Price
$23.24
$0.26
Analyst Decision
Strong Buy
Hold
Analyst Count
4
3
Target Price
★ $28.50
$5.50
AVG Volume (30 Days)
★ 823.4K
324.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 21.72
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$27.03
$445.09
Revenue Next Year
$29.21
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.41
$0.26
52 Week High
$52.88
$3.53

Technical Indicators

Market Signals
Indicator
BKSY
IMMP
Relative Strength Index (RSI) 49.80 29.26
Support Level $20.05 N/A
Resistance Level $24.35 $0.40
Average True Range (ATR) 1.31 0.02
MACD 0.37 -0.01
Stochastic Oscillator 84.68 7.86

Price Performance

Historical Comparison
BKSY
IMMP

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a space-based technology company that delivers real-time imagery, analytics and high-frequency monitoring of the worlds critical and strategic locations, economic assets, and events. By taking a software-first technology approach, Company is delivering real-time space-based intelligence at disruptive speed, scale and economics. Companies single operating and reportable segment, provided space-based intelligence products and services through three integrated revenue streams-space-based intelligence & AI services, mission solutions, and technology programs. Geographically, the company operates in United States and Rest of world.

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: